Author

Roberto Gasparini

Professore di Igiene e Medicina Preventiva Universit

Biography

Roberto Gasparini  is currently working as a Professor in the Department of Health Sciences. His research interests includes Medicine. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his Administrative responsibilities. Roberto Gasparini  has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis
A Domnich, L Arata, D Amicizia, J Puig-Barberà, R Gasparini, D PanattoVaccine 35 (4), 513-520, 2017201
216
2017
Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes
C Alicino, NL Bragazzi, V Faccio, D Amicizia, D Panatto, R Gasparini, ...Infectious diseases of poverty 4 (1), 1-13, 2015201
158
2015
Development and validation of the Italian version of the Mobile Application Rating Scale and its generalisability to apps targeting primary prevention
A Domnich, L Arata, D Amicizia, A Signori, B Patrick, S Stoyanov, L Hides, ...BMC Medical Informatics and Decision Making 16 (1), 1-10, 2016201
75
2016
Flucelvax (Optaflu) for seasonal influenza
I Manini, A Domnich, D Amicizia, S Rossi, T Pozzi, R Gasparini, D Panatto, ...Expert review of vaccines 14 (6), 789-804, 2015201
65
2015
The" urban myth" of the association between neurological disorders and vaccinations
R Gasparini, D Panatto, PL Lai, D AmiciziaJournal of preventive medicine and hygiene 56 (1), E1, 2015201
51
2015
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014
S Marchi, CM Trombetta, R Gasparini, N Temperton, E MontomoliJournal of preventive medicine and hygiene 58 (1), E27, 2017201
51
2017
Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview
NL Bragazzi, A Orsi, F Ansaldi, R Gasparini, G IcardiHuman vaccines & immunotherapeutics 12 (10), 2616-2627, 2016201
41
2016
Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)
D Amicizia, L Arata, F Zangrillo, D Panatto, R GaspariniJournal of preventive medicine and hygiene 58 (1), E1, 2017201
39
2017
Age-related differences in the accuracy of web query-based predictions of influenza-like illness
A Domnich, D Panatto, A Signori, PL Lai, R Gasparini, D AmiciziaPLoS One 10 (5), e0127754, 2015201
36
2015
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
R Gasparini, P Landa, D Amicizia, G Icardi, W Ricciardi, C De Waure, ...Human vaccines & immunotherapeutics 12 (8), 2148-2161, 2016201
34
2016
Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine and commonly administered vaccines after coadministration
R Gasparini, M Tregnaghi, P Keshavan, E Ypma, L Han, I SmolenovThe Pediatric Infectious Disease Journal 35 (1), 81-93, 2016201
32
2016
Trends in overweight and obesity prevalence in Tuscan schoolchildren (2002–2012)
G Lazzeri, D Panatto, A Pammolli, E Azzolini, R Simi, V Meoni, ...Public health nutrition 18 (17), 3078-3085, 2015201
27
2015
One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during …
O Henry, J Brzostek, H Czajka, G Leviniene, O Reshetko, R Gasparini, ...Vaccine 36 (3), 381-387, 2018201
25
2018
Clustering of health-related behaviors among early and mid-adolescents in Tuscany: results from a representative cross-sectional study
G Lazzeri, D Panatto, A Domnich, L Arata, A Pammolli, R Simi, ...Journal of Public Health 40 (1), e25-e33, 2018201
23
2018
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines
R Gasparini, D Panatto, NL Bragazzi, PL Lai, A Bechini, M Levi, ...Journal of immunology research 2015, 2015201
23
2015
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation
D Panatto, D Amicizia, L Arata, PL Lai, R GaspariniHuman Vaccines & Immunotherapeutics 14 (4), 969-977, 2018201
21
2018
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention
D Panatto, A Domnich, R Gasparini, P Bonanni, G Icardi, D Amicizia, ...Human Vaccines & Immunotherapeutics 12 (4), 1080-1084, 161
20
2016
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The …
A Bechini, P Bonanni, S Lauri, E Tiscione, M Levi, R Prato, F Fortunato, ...Human Vaccines & Immunotherapeutics 13 (2), 369-375, 2017201
19
2017
Antimeningococcal and antipneumococcal vaccination determinants: a European systematic literature review
V Malerba, C Costantino, G Napoli, V Marchese, A Casuccio, G Tabacchi, ...Epidemiologia e prevenzione 39, 59-64, 2015201
19
2015
Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies
R Gasparini, D Amicizia, PL Lai, D PanattoJournal of preventive medicine and hygiene 57 (1), E1, 2016201
18
2016

Referred From: https://scholar.google.co.jp/citations?user=r7Bg0yYAAAAJ&hl=it

Cited by
Citations 6151
h-index 44
i10-index 120
Recommended Journals
Open Access Journals